Added to YB: 2024-06-06
Pitch date: 2024-03-31
NTRA [bullish]
Natera, Inc.
+207.25%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
Market Cap
$40.0B
Pitch Price
$90.91
Price Target
N/A
Dividend
N/A
EV/EBITDA
-159.25
P/E
-170.83
EV/Sales
15.66
Sector
Biotechnology
Category
growth
Show full summary:
Alger Weatherbie Specialized Growth Fund Portfolio Holding: Natera, Inc.
NTRA: Specialty genetic testing lab for reproductive health, oncology (Signatera), transplant (Prospera). Q4 beat on strong Signatera growth & higher reimbursement rates. Gross margins expanding, guiding cash flow breakeven 2H24. Raised 2024 rev & margin guidance above expectations.
Read full article (1 min)